Identification

Description


Formule moléculaire brute : C3H2ClF5O

Principaux synonymes

Noms français :

  • Chloro-2 difluorométhoxy-2 trifluoro-1,1,1 éthane
  • Isoflurane

Noms anglais :

  • 1-Chloro-2,2,2-trifluoroethyl difluoromethyl ether
  • Ethane, 2-chloro-2-(difluoromethoxy)-1,1,1-trifluoro-
  • Ether, 1-chloro-2,2,2-trifluoroethyl difluoromethyl-
Utilisation et sources d'émission 1 2 3

L'isoflurane est utilisé comme agent anesthésiant par inhalation.

Références

  • ▲1.  Sax's dangerous properties of industrial materials. 11th ed. Hoboken, N.J. : John Wiley & Sons. (2004). [RR-014005]
  • ▲2.  INRS, DEMETER : documents pour l'évaluation médicale des produits toxiques vis-à-vis de la reproduction. Paris : Institut national de recherche et de sécurité pour la prévention des accidents du travail et des maladies professionnelles. (2006).   http://www.inrs.fr/publications/bdd/demeter.html
  • ▲2.  INRS, DEMETER : documents pour l'évaluation médicale des produits toxiques vis-à-vis de la reproduction. Paris : Institut national de recherche et de sécurité pour la prévention des accidents du travail et des maladies professionnelles. (2006).   http://www.inrs.fr/publications/bdd/demeter.html
  • ▲3.  O'Neil, M.J. et al., The Merck Index : an encyclopedia of chemicals, drugs, & biologicals. 15e éd. Cambridge, G.-B. : Royal Society of Chemistry. (2013). [RM-403001]   https://www.rsc.org/Merck-Index/
  • ▲3.  O'Neil, M.J. et al., The Merck Index : an encyclopedia of chemicals, drugs, & biologicals. 15e éd. Cambridge, G.-B. : Royal Society of Chemistry. (2013). [RM-403001]   https://www.rsc.org/Merck-Index/
  • ▲4.  Kroschwitz, J.I., Kirk-Othmer encyclopedia of chemical technology. 5th ed. Hoboken, N.J. : John Wiley & Sons. (2004-). [RT-423004]
  • ▲5.  Deutsche Forschungsgemeinschaft. Kommission zur Prüfung Gesundheitsschädlicher Arbeitsstoffe, Occupational toxicants : critical data evaluation for MAK values and classification of carcinogens. Weinheim; New York : VCH. (1991-). [MO-020680]   www.wiley-vch.de
    www.mak-collection.com
    http://onlinelibrary.wiley.com/book/10.1002/3527600418/topics
  • ▲6.  Saber, A.T. et Hougaard, K.S., The Nordic Expert Group for Criteria Documentation of Health Risks from Chemicals 141. Isoflurane, sevoflurane and desflurane. Arbete och Hälsa, Vol. 43, 9. Gothenburg, Suède : University of Gothenburg. (2009).   https://gupea.ub.gu.se/dspace/handle/2077/3194?locale=en
    https://gupea.ub.gu.se/dspace/bitstream/2077/21413/1/gupea_2077_21413_1.pdf
  • ▲7.  Giroud, J.-P., Mathé, G. et Meyniel, G., Pharmacologie clinique : bases de la thérapeutique. 2e éd. Paris : Expansion Scientifique Française. (1988). [RM-414008]
  • ▲8.  Dale, O. et Brown, B.R., «Clinical pharmacokinetics of the inhalational anaesthetics.» Clinical Pharmacokinetics. Vol. 12, p. 145-167. (1987).
  • ▲9.  Munson, E.S., «Isoflurane.» Middle East J. Anaesthesiol. . Vol. 6, no. 4, p. 181-188. (1982).
  • ▲10.  Fiserova-Bergerova, V. et Holaday, D.A., «Uptake and clearance of inhalation anesthetics in man.» Drug Metabolism Reviews. Vol. 9, no. 1, p. 43-60. (1979).
  • ▲11.  Wissing, H. et al., «Pharmacokinetics of inhaled anaesthetics in a clinical setting : comparison of desflurane, isoflurane and sevoflurane.» British Journal of Anaesthesia. Vol. 84, p. 443-449. (2000).
  • ▲12.  Fassoulaki, A. et al., «Percutaneous loss of desflurane, isoflurane, and halothane in humans.» Anesthesiology. Vol. 74, p. 479-483. (1991).
  • ▲13.  Archives des maladies professionnelles, de médecine du travail et de sécurité sociale. Vol. 49, 4. (1988). [AP-022494]
  • ▲14.  Strum, D.P. et al., «Age affects the phamacokinetics of inhaled anesthetics in humans.» Anesthesia and Analgesia. Vol. 73, p. 310-318. (1991).
  • ▲15.  Waskell, L., Metabolism of the volatile anesthetics. New York : Raven Press. (1994).
  • ▲16.  McDougal, J.N. et al., «Dermal absorption of organic chemical vapors in rats and humans .» Fundamental and Applied Toxicology. Vol. 14, p. 299-308. (1990). [AP-026900]
  • ▲17.  Van Dyke, R.A., Toxic metabolites from biotransformation : major organ damage. International Anesthesiology Clinics, Vol. 19. Boston : Little, Brown and Company. (1981).
  • ▲18.  Lockhart, S.H. et al., «Comparison of percutaneous losses of sevoflurane and isoflurane in humans.» Anesthesia and Analgesia. Vol. 72, p. 212-215. (1991).
  • ▲19.  Vellore, A.D. et al., «Occupational asthma and allergy to sevoflurane and isoflurane in anaesthetic staff.» Allergy. Vol. 61, no. 12, p. 1485-1486. (2006).
  • ▲20.  Finch, T.M. et al., «Occupational airborne allergic contact dermatitis from isoflurane vapour.» Contact Dermatitis. Vol. 42, no. 1, p. 46. (2000).
  • ▲21.  Caraffini, S. et al., «Isoflurance : an uncommon cause of occupational airborne contact dermatitis.» Contact Dermatitis. Vol. 38, no. 5, p. 286. (1998).
  • ▲22.  Mazze, R.I. et al., «Reproductive and teratogenic effects of nitrous oxide, halothane, isoflurane, and enflurane in Sprague-Dawley rats.» Anesthesiology. Vol. 64, p. 339-344. (1986).
  • ▲23.  Dwyer, R., «Uptake of halothane and isoflurane by mother and baby during Caesarean section.» British Journal of Anaesthesia. Vol. 74, p. 379 - 383. (1995). [AP-058418]
  • ▲24.  Mazze, R.I. et al., «Fetal development in mice exposed to isoflurane.» Teratology. Vol. 32, no. 3, p. 339-345. (1985).
  • ▲25.  Kennedy, G.L. et al., «Reproductive and teratologic studies with isoflurane.» Drug and Chemical Toxicology. Vol. 1, no. 1, p. 75-88. (1977-78). [AP-058425]
  • ▲26.  Fujinaga, M. et al., «Reproductive and teratogenic effects of nitrous oxide, isoflurane, and their combination in Sprague-Dawley rats.» Anesthesiology. Vol. 67, p. 960-964. (1987).
  • ▲27.  Rice, S.A., «Behavioral effects of in utero isoflurane exposure in young SW mice.» Teratology. Vol. 33, no. 3, p. 100C-101C. (1986). [AP-040224]
  • ▲28.  Fisher, J. et al., «Lactational transfer of volatile chemicals in breast milk.» American Industrial Hygiene Association Journal. Vol. 58, no. 6, p. 425-431. (1997). [AP-051996]
  • ▲29.  Preib, A. et al., «The determination of trifluoroacetic acid in rat milk samples by 19F-NMR spectroscopy and capillary gas chromatography.» Journal of Pharmaceutical and Biochemical Analysis. Vol. 16, p. 1381-1385. (1998).
  • ▲30.  IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Overall evaluations of carcinogenicity : an updating of IARC monographs volumes 1-42. IARC monographs on the evaluation of carcinogenic risks to humans, Supplement 7. Lyon : International Agency for Research on Cancer. (1987).   https://monographs.iarc.fr/wp-content/uploads/2018/06/Suppl7.pdf
    http://monographs.iarc.fr/
  • ▲31.  IARC Working Group on the Evaluation of Carcinogenic Risks of Chemical to Man, Cadmium, nickel, some epoxides, miscellaneous industrial chemicals and general considerations on volatile anaesthetics. IARC monographs on the evaluation of carcinogenic risks of chemical to man, Vol. 11. Lyon : International Agency for Research on Cancer. (1976).   https://monographs.iarc.fr/wp-content/uploads/2018/06/mono11.pdf
    http://www.iarc.fr
  • ▲32.  Eger, E.I. et al., «A test of the carcinogenicity of enflurane, isoflurane, halothane, methoxyflurane, and nitrous oxide in mice.» Anesthesia and Analgesia. Vol. 57, p. 678-694. (1978).
  • ▲33.  Corbett, T.H., «Cancer and congenital anomalies associated with anesthetics.» Annals of the New York Academy of Sciences. Vol. 271, p. 58-66. (1976).
  • ▲34.  Baden, J.M. et al., «Carcinogen bioassay of isoflurane in mice.» Anesthesiology. Vol. 69, p. 750-753. (1988).
  • ▲35.  Robbiano, L. et al., «Increased frequency of micronucleated kidney cells in rats exposed to halogenated anaesthetics.» Mutation Research. Vol. 413, p. 1-6. (1998).
  • ▲36.  White, A.E. et al., «Sister chromatid exchanges induced by inhaled anesthetics.» Anesthesiology. Vol. 50, p. 426-430. (1979).
  • ▲37.  Trudnowski, R.J., Mehta, M.P. et Rucinski, M., «Evaluation of the mutagenic potential of enflurane and isoflurane by sister chromatid exchange.» Journal of Medicine. Vol. 18, no. 1, p. 55-60. (1987).
  • ▲38.  Hoerauf, K.H. et al., «Sister chromatid exchange in human lymphocytes exposed to isoflurane and nitrous oxide in vitro.» British Journal of Anaesthesia. Vol. 82, no. 2, p. 268-270. (1999).
  • ▲39.  Jaloszynski, P. et al., «Genotoxicity of inhalation anesthetics halothane and isoflurane in human lymphocytes studied in vitro using comet assay.» Mutation Research. Vol. 439, p. 199-206. (1999).
  • ▲40.  National Institute for Occupational Safety and Health, RTECS (Registry of Toxic Effects of Chemical Substances). Hamilton (Ont) : Canadian Centre for Occupational Health and Safety.   http://ccinfoweb.ccohs.ca/rtecs/search.html
  • ▲41.  National Library of Medicine, The Hazardous Substances Data Bank (HSDB). Hamilton (Ont.) : Canadian Centre for Occupational Health and Safety.   http://www.ccohs.ca/
  • ▲42.  Centre canadien d'hygiène et de sécurité au travail, CHEMINFO, Hamilton, Ont. : Canadian Centre for Occupational Health and Safety   http://ccinfoweb.ccohs.ca/cheminfo/search.html

La cote entre [ ] provient de la banque Information SST du Centre de documentation de la CNESST.